Arq. NeuroPsiquiatr. vol.74 número3

Oligoclonal bands in the cerebrospinal luid and increased brain atrophy in early stages of relapsing-remitting

This article describes the clinical and radiological evolution of a stable group of patients with relapsing-remitting multiple sclerosis that had their disease-modifying therapy

Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel- based morphometry study.. Jacob A, McKeon A, Nakashima I,

Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod

Safety and efficacy of fingolimod in patients with relapsing- remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. Polman

Objective: A 4.5-year follow-up study was conducted to characterize baseline verbal episodic memory (VEM) and its behavior and to assess the effects of relapsing-remitting

Num estudo retrospetivo multicêntrico, a administração de quimioterapia adjuvante esteve associa- da a melhor progressão livre de doença, mas não a melhor sobrevivência global.. 30

In the present study, we evaluated CSF levels of CXCL10, CCL2 and CCL5 in active RR-MS and stable RR-MS patients and in individuals with no neurological disorders.. The CSF levels